Mar 24 2023
England Allows Gene-Edited Crops
This has been somewhat of a quiet revolution, but a new law in England may bring it to the foreground. The Precision Breeding Act will now allow gene-edited plants to be developed and marketed in England (not Northern Ireland, Wales, or Scotland). The innovation is that the law makes a distinction between genetically modified organisms (GMOs) and gene-edited organisms. This has already happened in the US, with the USDA declaring that gene-editing is not the same as GMO, for regulatory purposes.
GMO has always been, in my opinion, a category that is both arbitrary and overly broad. It has referred to any organism (usually a crop) that is the result of genetic engineering using a variety of techniques. This could include silencing a gene, removing a gene, or introducing a new gene either from a related variety (cisgenic) or a distant species (transgenic). Most of the fearmongering (and that’s what it is) around GMOs have been focused on transgenic varieties, but then used to try to ban the entire category. The newer regulations, essentially, limit GMO to transgenic changes, and refer to everything else as gene-edited. This is often described as changes that could theoretically occur with breeding techniques, now just faster.
This is all good, because it restricts the damage done by anti-GMO fearmongering. It’s still wrong, it’s just not casting as wide a net. To show how arbitrary this all is, most restrictions on GMOs make exceptions for cheese made with enzymes that are the product of engineered yeast. Why? Because the cheese industry would collapse without it. Similarly, Hawaii, which is ideologically very anti-GMO, made an exception for GMO papaya. Why? You guessed it – because without it they would have lost their papaya industry.

This is one of those technology news stories where the implications of the technology is greater than the thing itself. Relativity Space, a rocket company based in California,
Are you familiar with the “lumper vs splitter” debate? This refers to any situation in which there is some controversy over exactly how to categorize complex phenomena, specifically whether or not to favor the fewest categories based on similarities, or the greatest number of categories based on every difference. For example, in medicine we need to divide the world of diseases into specific entities. Some diseases are very specific, but many are highly variable. For the variable diseases do we lump every type into a single disease category, or do we split them into different disease types? Lumping is clean but can gloss-over important details. Splitting endeavors to capture all detail, but can create a categorical mess.
Did UFO reporting increase during the pandemic? A group of researchers set out to answer that question,
The nuclear debate seems never-ending, which I guess is to be expected. Every large technology has tradeoffs. But the need to transition our energy infrastructure to carbon neutral has shifted the equation, and it is now arguable that we cannot afford to ignore the option of nuclear energy. The UK seems to agree with this take – they currently generate about 15.5% of their energy through nuclear reactors and are
Good spacesuits are deceptively difficult to design, even with today’s technology. NASA is planning to return to the moon in 2025 (if all goes well) but the spacesuit the astronauts will wear is one piece to the puzzle they have not completed yet (the other being the lunar lander). In fact, NASA spent $420 million on spacesuit development but was unhappy with the results. They therefore contracted out the design to private industry. Axiom space won a $228 million contract and
There has been a lot of quantum computer news
NASA 
Psychiatry, psychology, and all aspects of mental health are a challenging area because the clinical entities we are dealing with are complex and mostly subjective. Diagnoses are perhaps best understood as clinical constructs – a way of identifying and understanding a mental health issue, but not necessary a core neurological phenomenon. In other words, things like bipolar disorder are identified, categorized, and diagnosed based upon a list of clinical signs and symptoms. But this is a descriptive approach, and may not correlate to specific circuitry in the brain. Researchers are making progress finding the “neuroanatomical correlates” of known clinical entities, but such correlates are mostly partial and statistical. Further, there is culture, personality, and environment to deal with, which significantly influences how underlying brain circuitry manifests clinically. Also, not all mental health diagnoses are equal – some are likely to be a lot closer to discrete brain circuitry than others.




